Clinical Trial Update: GON-block in Chronic Migraine: a Randomized, Double- Blind, Placebo-controlled Study [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind, placebo-controlled trial of GON-block for chronic migraine; the current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Jakob Møller Hansen, MD. | Conditions: Chronic Migraine | Phase 4 | Status: UNKNOWN